18987279

Legro RS

2008

Impact of metformin, oral contraceptives, and lifestyle modification on polycystic ovary syndrome in obese adolescent women: do we need a new drug?

18987293

Abell S

2008

Polycystic ovarian syndrome.

18990375

Smorgick N

2009

The clinical characteristics and sonographic findings of maternal ovarian torsion in pregnancy.

18990384

Orvieto R

2009

Chronic ultra-low dose follicle-stimulating hormone regimen for patients with polycystic ovary syndrome: one click, one follicle, one pregnancy.

18997670

Luque-Ram?rez M

2009

Antiandrogenic contraceptives increase serum adiponectin in obese polycystic ovary syndrome patients.

19003660

Warrington C

2008

Endometrial thickness and outcome in sub-fertile women treated with clomiphene citrate.

19007635

Practice Committee of American Society for Reproductive Medicine.

2008

Current evaluation of amenorrhea.

19007650

Practice Committee of American Society for Reproductive Medicine.

2008

Use of insulin-sensitizing agents in the treatment of polycystic ovary syndrome.

19007651

Practice Committee of American Society for Reproductive Medicine.

2008

Use of exogenous gonadotropins in anovulatory women: a technical bulletin.

19009369

UKINC K

2009

Diagnostic value of prostate-specific antigen (PSA) and free prostate specific antigen (fPSA) in women with ovulatory and anovulatory polycystic ovary syndrome.

19012098

Liao LM

2008

Exercise and body image distress in overweight and obese women with polycystic ovary syndrome: a pilot investigation.

19012099

Bilo L

2008

Polycystic ovary syndrome in women using valproate: a review.

19012100

Soyupek F

2008

Evaluation of hand functions in women with polycystic ovary syndrome.

19012104

Jing Z

2008

The effects of Diane-35 and metformin in treatment of polycystic ovary syndrome: an updated systematic review.

19013303

Echibur? B

2008

Polymorphism T --> C (-34 base pairs) of gene CYP17 promoter in women with polycystic ovary syndrome is associated with increased body weight and insulin resistance: a preliminary study.

19013863

Escobar-Morreale HF

2008

Polycystic ovary syndrome: treatment strategies and management.

19017415

Angioni S

2008

Diagnosis of metabolic disorders in women with polycystic ovary syndrome.

19019358

Teede HJ

2010

Endothelial function and insulin resistance in polycystic ovary syndrome: the effects of medical therapy.

19024638

Gianola FJ

2008

The physician assistant's professional obligations and the values of faith.

19024937

Dewailly D

2008

[Obesity and polycystic ovary syndrome: reproductive issues].

19027112

Chen Y

2009

Selective impairment in glycogen synthase kinase-3 and mitogen-activated protein kinase phosphorylation: comparisons with the hyperandrogenic and the hyperinsulinemic rats.

19027116

Rajendran S

2009

Polycystic ovary syndrome is associated with severe platelet and endothelial dysfunction in both obese and lean subjects.

19028383

Chan TF

2010

Serum retinol-binding protein 4 levels in nonobese women with polycystic ovary syndrome.

19031219

Mitkov M

2008

Serum ghrelin level in women with polycystic ovary syndrome and its relationship with endocrine and metabolic parameters.

19031220

Pascual MA

2008

Assessment of ovarian vascularization in the polycystic ovary by three-dimensional power Doppler ultrasonography.

19031221

Kulshreshtha B

2008

Insulin response to oral glucose in healthy, lean young women and patients with polycystic ovary syndrome.

19032932

Lin X

2009

Human sodium/inositol cotransporter 2 (SMIT2) transports inositols but not glucose in L6 cells.

19033128

Yang MQ

2008

[Effect of two different doses of letrozole in promoting ovulation in infertile women with polycystic ovarian syndrome].

19033451

Ghobadi C

2009

Single-dose pharmacokinetic study of clomiphene citrate isomers in anovular patients with polycystic ovary disease.

19037680

Sand M

2008

[Hair removal in patients with pigmented hair follicles].

19039232

Codner E

2009

Puberty and ovarian function in girls with type 1 diabetes mellitus.

19049992

Wang K

2009

No association of the Arg51Gln and Leu72Met polymorphisms of the ghrelin gene and polycystic ovary syndrome.

19053948

Rajkhowa M

2009

Insulin resistance in polycystic ovary syndrome is associated with defective regulation of ERK1/2 by insulin in skeletal muscle in vivo.

19056992

Palomba S

2009

Evidence-based and potential benefits of metformin in the polycystic ovary syndrome: a comprehensive review.

19057990

Cetinkalp S

2009

Apolipoprotein E gene polymorphism and polycystic ovary syndrome patients in Western Anatolia, Turkey.

19059532

Villeneuve MC

2009

Hyperinsulinemia is closely related to low urinary clearance of D-chiro-inositol in men with a wide range of insulin sensitivity.

19062007

Moran LJ

2009

Treatment of obesity in polycystic ovary syndrome: a position statement of the Androgen Excess and Polycystic Ovary Syndrome Society.

19064229

Chen Y

2008

The role of ovarian volume as a diagnostic criterion for Chinese adolescents with polycystic ovary syndrome.

19064264

Liberty G

2010

Ovarian hemorrhage after transvaginal ultrasonographically guided oocyte aspiration: a potentially catastrophic and not so rare complication among lean patients with polycystic ovary syndrome.

19066200

Bagos PG

2009

Plasminogen activator inhibitor-1 4G/5G and 5,10-methylene-tetrahydrofolate reductase C677T polymorphisms in polycystic ovary syndrome.

19068018

Kawamura S

2008

Conduct disorder in an adolescent girl treated with an insulin-sensitizing agent.

19072461

Christakou CD

2008

Role of androgen excess on metabolic aberrations and cardiovascular risk in women with polycystic ovary syndrome.

19072515

Robertson DM

2008

Anti-M?llerian hormone as a marker of ovarian reserve: an update.

19072520

Zain MM

2008

Impact of obesity on female fertility and fertility treatment.

19076945

Atiomo W

2009

Proteomic biomarkers for the diagnosis and risk stratification of polycystic ovary syndrome: a systematic review.

19078868

Nardo LG

2008

Polycystic ovary syndrome: pathophysiology, molecular aspects and clinical implications.

19078869

Corbould A

2008

Insulin resistance in skeletal muscle and adipose tissue in polycystic ovary syndrome: are the molecular mechanisms distinct from type 2 diabetes?

19078870

Bethea SW

2008

Comorbidities in polycystic ovary syndrome: their relationship to insulin resistance.

19078871

Hart R

2008

PCOS and infertility.

19078872

Diamanti-Kandarakis E

2008

Pancreatic beta-cells dysfunction in polycystic ovary syndrome.

19080630

Zhu MW

2008

[Characteristics of quantitative change relation between insulin and testosterone in polycystic ovary syndrome].

19082308

Marcondes JA

2008

Ovarian hyperthecosis in the context of an adrenal incidentaloma in a postmenopausal woman.

19084097

Mathur R

2008

Use of metformin in polycystic ovary syndrome.

19085702

Tekin A

2009

Left ventricular function in patients with polycystic ovary syndrome: a Doppler echocardiographic study.

19086993

Sugiura-Ogasawara M

2009

The polycystic ovary syndrome does not predict further miscarriage in Japanese couples experiencing recurrent miscarriages.

19087082

Signorelli M

2009

Fertility-sparing treatment in young women with endometrial cancer or atypical complex hyperplasia: a prospective single-institution experience of 21 cases.

19087489

Chen ZJ

2008

[Clinical analysis of assistant treatment proposals for infertile women with polycystic ovary syndrome].

19090443

Stroh C

2008

[PCO syndrome--is it an indication for bariatric surgery?].

19090942

Battaglia C

2008

PCOS, sexuality, and clitoral vascularisation: a pilot study.

19092235

Rezvanian H

2009

Increased insulin sensitivity by metformin enhances intense-pulsed-light-assisted hair removal in patients with polycystic ovary syndrome.

19094071

Soares GM

2009

Increased arterial stiffness in nonobese women with polycystic ovary syndrome (PCOS) without comorbidities: one more characteristic inherent to the syndrome?

19094425

Ferk P

2008

Insulin gene polymorphism in women with polycystic ovary syndrome.

19094426

Adali E

2008

The relationship between clinico-biochemical characteristics and psychiatric distress in young women with polycystic ovary syndrome.

19094427

Yildizhan R

2008

Ovarian stimulation in obese and non-obese polycystic ovary syndrome using a low-dose step-up regimen with two different starting doses of recombinant follicle-stimulating hormone.

19095671

da Silva BB

2009

Evaluation of Ki-67 antigen expression in the zona reticularis of the adrenal cortex of female rats in persistent estrus.

19095675

Goverde AJ

2009

Indicators for metabolic disturbances in anovulatory women with polycystic ovary syndrome diagnosed according to the Rotterdam consensus criteria.

19097595

Horng SG

2008

Estradiol-to-testosterone ratio is associated with response to metformin treatment in women with clomiphene citrate-resistant polycystic ovary syndrome (PCOS).

19100535

Okutsu Y

2010

Exogenous androstenedione induces formation of follicular cysts and premature luteinization of granulosa cells in the ovary.

19100540

Hendriks ML

2010

Extensive tissue damage of bovine ovaries after bipolar ovarian drilling compared to monopolar electrocoagulation or carbon dioxide laser.

19100956

Ramidi G

2009

Enoxaparin-metformin and enoxaparin alone may safely reduce pregnancy loss.

19107018

Verdaguer M

2008

[Obstructive sleep apnoea syndrome (OSAS) in women: a specific entity?].

19107500

Kebapcilar L

2009

High mean platelet volume, low-grade systemic coagulation and fibrinolytic activation are associated with androgen and insulin levels in polycystic ovary syndrome.

19107990

Scharfman HE

2008

Seizures and reproductive function: insights from female rats with epilepsy.

19108828

Li L

2009

Genetic variations of solute carrier family 30 (zinc transporter) member 8 (SLC30A8) are not associated with polycystic ovary syndrome.

19108830

Pamuk BO

2010

Asymmetric dimethylarginine levels and carotid intima-media thickness in obese patients with polycystic ovary syndrome and their relationship to metabolic parameters.

19111298

Ozkaya M

2010

Effect of metformin on serum visfatin levels in patients with polycystic ovary syndrome.

19114272

Hurst BS

2009

Novel clomiphene stair-step protocol reduces time to ovulation in women with polycystic ovarian syndrome.

19114623

Escobar-Morreale HF

2009

Serum visceral adipose tissue-derived serine protease inhibitor concentrations in human obesity and polycystic ovary syndrome.

19123007

Gumus II

2009

Polycystic ovary syndrome and fibrocystic breast disease: is there any association?

19125266

Ozcimen EE

2009

The effect of metformin treatment on ovarian stromal blood flow in women with polycystic ovary syndrome.

19125993

Berneis K

2009

Atherogenic forms of dyslipidaemia in women with polycystic ovary syndrome.

19126632

Hoeger KM

2009

Polycystic ovary syndrome, inflammation, and statins: do we have the right target?

19127427

Ganesh A

2009

Comparison of letrozole with continuous gonadotropins and clomiphene-gonadotropin combination for ovulation induction in 1387 PCOS women after clomiphene citrate failure: a randomized prospective clinical trial.

19128368

Sathyapalan T

2009

Metformin maintains the weight loss and metabolic benefits following rimonabant treatment in obese women with polycystic ovary syndrome (PCOS).

19129710

Eyzaguirre F

2009

Insulin resistance markers in children.

19131059

Kaya C

2010

Plasma interleukin-18 levels are increased in the polycystic ovary syndrome: relationship of carotid intima-media wall thickness and cardiovascular risk factors.

19135667

Franceschi R

2010

Prevalence of polycystic ovary syndrome in young women who had idiopathic central precocious puberty.

19139031

Luque-Ram?rez M

2009

Effects of an antiandrogenic oral contraceptive pill compared with metformin on blood coagulation tests and endothelial function in women with the polycystic ovary syndrome: influence of obesity and smoking.

19141465

Vigil P

2009

Scanning electron and light microscopy study of the cervical mucus in women with polycystic ovary syndrome.

19141487

Kenigsberg S

2009

Gene expression microarray profiles of cumulus cells in lean and overweight-obese polycystic ovary syndrome patients.

19141577

Kim JY

2009

Transcriptional profiling with a pathway-oriented analysis identifies dysregulated molecular phenotypes in the endometrium of patients with polycystic ovary syndrome.

19142493

Santana LF

2008

[Treatment of infertility in women with polycystic ovary syndrome].

19142499

Vieira RC

2008

[Evaluation of meiotic abnormalities of oocytes from polycystic ovary syndrome patients submitted to ovarian stimulation].

19142502

de Azevedo GD

2008

[Lifestyle modifications in the polycystic ovary syndrome: role of physical exercise and importance of multidisciplinary approach].

19145943

Marciniak A

2008

[The role of leptin in polycystic ovary syndrome].

19146764

Lainas TG

2009

Management of severe OHSS using GnRH antagonist and blastocyst cryopreservation in PCOS patients treated with long protocol.

19146765

Vrtacnik-Bokal E

2009

Follicular oestradiol and VEGF after GnRH antagonists or GnRH agonists in women with PCOS.

19146766

Benkhalifa M

2009

Natural cycle IVF and oocyte in-vitro maturation in polycystic ovary syndrome: a collaborative prospective study.

19147136

Thomson RL

2010

Heart rate recovery improves after weight loss in overweight and obese women with polycystic ovary syndrome.

19150179

Benson S

2009

Disturbed stress responses in women with polycystic ovary syndrome.